Validation of the CLAD Score Ifor Renal Colic Pain

Renal Colic Clinical Trial

— CLAD-V  

Official title:

Prospective Validation of the CLAD Score in Patients Admitted to an Emergency Facility for Renal Colic Pain

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT06026072
• Other study ID #: RC31/21/0124
• Secondary ID: 2021-A00807-34
• Status: Completed
• Phase: N/A
• Start date: July 6, 2021
• Est. completion date: July 30, 2023

Study information

• Verified date: August 2023
• Source: University Hospital, Toulouse
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Renal colic is a frequent reason for recourse representing 1 to 2% of emergency room admissions. This study would validate the performance of the CLAD score in predicting the need for surgical management within 7 days of patients admitted to the emergency department for renal colic pain.

Description:

Renal colic is a frequent reason for recourse representing 1 to 2% of emergency room admissions. It results clinically in a lumbo-abdominal pain syndrome radiating into the genitals. The origin of this pain is the tensioning of the urinary tract, most frequently by a lithiasis creating a transient obstruction Toulouse medical team has developed the "Complicated uroLithiasis and Alternative Diagnosis" (CLAD) score, which predicts the risk of requiring surgery within 7 days of admission of patients to the emergency room for renal colic The aim of this study is to validate this CLAD-V score by collecting the elements of the CLAD score and the clinician's intuition is made available to practitioners in the emergency department. All patients presenting to the emergency room for renal colic pain are eligible. The doctor in charge of the patient will have to examine him and take care of him according to the service protocol. The doctor must then complete the questionnaire provided. A reminder of the patient on D7 is carried out to collect information on the need for surgery after the emergency or not. Each center ensures inclusions and reminders on D7 and will only transmit the database

Recruitment information / eligibility

• Status: Completed
• Enrollment: 1200
• Est. completion date: July 30, 2023
• Est. primary completion date: July 6, 2023
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years to 100 Years

Eligibility

Inclusion Criteria:

• Adult patients admitted to the emergency room for suspected renal colic
• Patient not objecting to participation

Exclusion Criteria:

• Patients unable to express their non-objection
• Pregnant women

Related Conditions & MeSH terms

• Colic
• Renal Colic

Intervention

Other:
• CLAD-V SCORE
the CLAD-V score is measured by the doctor during the emergency take care. After 7 days the patient will be call back to compare the prediction of CLAD-V score and the reality of surgical intervention or no.

Locations

Country	Name	City	State
France	CHU de Toulouse	Toulouse	Haute-Garonne

Sponsors (1)

Lead Sponsor	Collaborator
University Hospital, Toulouse

Country where clinical trial is conducted

France, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	CLAD-V performance	Validate the performance of the CLAD score in predicting the need for surgical management within 7 days of patients admitted to the emergency department for renal colic pain	7 days